Current applications see these receptor agonists being used more regularly for obesity management leading to decreasing appetite sensations and feelings of hunger while conversely increasing satiety post-consumption
Some of the findings include the following: In a 2022 trial, subjects taking 1,000mg of urolithin A exhibited clinically meaningful improvements in their aerobic endurance and physical performance when compared to subjects who took either 500mg or a placebo.5 A separate 2022 trial examined the effects of 1,000mg urolithin A versus placebo in older adults after four months of daily supplementation
Trusted by the research community with 4.9-star Trustpilot & PepReviewPro ratings and over 700+ verified customer reviews.
Lifestyle modificationweight loss, physical activity, and dietary changesremains the most effective evidence-based treatment for NAFLD as per NICE guidance
Semaglutide, a GLP-1 receptor agonist used for type 2 diabetes and weight management, should always appear as a clear, colorless solution